CSTL · Insider Trading

Castle Biosciences, Inc. Common Stock

Every open-market purchase and sale reported by CSTL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
19
code S
Reporting Insiders
11
current holders
CSTL — Recent Form 4 Transactions (latest 2026-11-18)
FiledInsiderRole TypeSharesValue
2026-11-18 Derek J Maetzold Pres. & Chief Exec. Officer Sell −6,942 −$228.53K
2026-11-13 Tobin W Juvenal Chief Commercial Officer MIXED — −$17.80K
2026-11-12 Tobin W Juvenal Chief Commercial Officer Sell −6,116 −$206.52K
2026-11-04 Derek J Maetzold Pres. & Chief Exec. Officer Sell −14,496 −$523.33K
2026-10-30 Tobin W Juvenal Chief Commercial Officer Sell −6,578 −$239.59K
2026-10-28 Tobin W Juvenal Chief Commercial Officer Sell −3,288 −$108.77K
2026-10-21 Derek J Maetzold Pres. & Chief Exec. Officer Sell −14,496 −$462.57K
2026-10-14 Tobin W Juvenal Chief Commercial Officer Sell −3,288 −$110.61K
2026-10-07 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −6,331 −$496.05K
2026-10-05 Kristen M Oelschlager Chief Operating Officer MIXED — −$135.28K
2026-10-01 Tobin W Juvenal Chief Commercial Officer Sell −6,577 −$232.13K
2026-09-23 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −5,916 −$491.70K
2026-09-16 Tobin W Juvenal Chief Commercial Officer Sell −6,600 −$222.62K
2026-09-15 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −5,934 −$444.35K
2026-09-03 Kristen M Oelschlager Chief Operating Officer MIXED — −$124.61K
2026-09-02 Tobin W Juvenal Chief Commercial Officer Sell −1,730 −$56.76K
2026-09-01 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −6,132 −$586.43K
2026-08-27 Tobin W Juvenal Chief Commercial Officer Sell −9,050 −$317.11K
2026-08-26 Kristen M Oelschlager Chief Operating Officer Sell −24,602 −$837.86K
2026-08-19 Tobin W Juvenal Chief Commercial Officer Sell −1,730 −$51.19K
2026-08-18 Frank Stokes Chief Financial Officer Sell −24,908 −$741.51K
2026-08-18 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −6,132 −$214.48K
2026-08-06 Tobin W Juvenal Chief Commercial Officer Sell −1,301 −$49.95K
2026-08-06 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −16,114 −$1.16M
2026-08-05 Kristen M Oelschlager Chief Operating Officer Sell −8,586 −$255.62K
2026-08-04 Tobin W Juvenal Chief Commercial Officer Sell −19,040 −$556.17K
2026-08-04 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −11,502 −$826.48K
2026-07-29 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −3,622 −$222.83K
2026-07-16 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −3,622 −$94.31K
2026-07-06 Kristen M Oelschlager Chief Operating Officer Sell −8,586 −$209.65K
2026-07-06 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −3,622 −$224.06K
2026-06-18 Kristen M Oelschlager Chief Operating Officer Sell −8,587 −$177.84K
2026-06-17 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −3,622 −$84.88K
2026-06-03 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −3,622 −$190.30K
2026-06-01 Daniel Bradbury Director A +11,766 deriv. —
2026-06-01 Rodney Cotton Director A +11,766 deriv. —
2026-06-01 G Bradley Cole Director A +11,766 deriv. —
2026-06-01 Ellen Goldberg Director A +11,766 deriv. —
2026-06-01 Miles Harrison Director A +11,766 deriv. —
2026-06-01 Kim Caple Director A +11,766 deriv. —
2026-06-01 Tiffany Olson Director A +11,766 deriv. —
2026-05-27 Kim Caple Director M +13,667 —
2026-05-27 Ellen Goldberg Director M +13,667 —
2026-05-27 Tiffany Olson Director M +13,667 —
2026-05-27 Miles Harrison Director M +13,667 —
2026-05-27 Daniel Bradbury Director M +13,667 —
2026-05-27 G Bradley Cole Director M +13,667 —
2026-05-27 Rodney Cotton Director M +13,667 —
2026-05-26 Tobin W Juvenal Chief Commercial Officer M +11,210 +$37.89K
2026-05-22 Derek J Maetzold Pres. & Chief Exec. Officer MIXED −3,622 −$82.75K
CSTL — Current Insider Holders
InsiderRole Shares HeldValue
Derek J Maetzold Pres. & Chief Exec. Officer 149,000 $5.03M
Kristen M Oelschlager Chief Operating Officer 87,351 $2.95M
Ellen Goldberg Director 40,921 $1.38M
Tiffany Olson Director 39,573 $1.34M
Kim Caple Director 36,121 $1.22M
Daniel Bradbury Director 35,631 $1.20M
Miles Harrison Director 35,631 $1.20M
Frank Stokes Chief Financial Officer 35,177 $1.19M
Tobin W Juvenal Chief Commercial Officer 34,967 $1.18M
Rodney Cotton Director 32,998 $1.12M
G Bradley Cole Director 32,976 $1.11M
CSTL Insider Trading FAQ
Who are the insiders at CSTL?
11 officers, directors and 10%+ beneficial owners currently report holdings in CSTL via SEC Form 4.
Are CSTL insiders buying or selling?
Across the 50 most recent Form 4 filings for CSTL, 0 were open-market purchases (code P) and 19 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is CSTL insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent CSTL filing is dated 2026-11-18.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the CSTL quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.